Table 5.
Expression of proangiogenic factors and MVD according to the grade of ovarian cancer
G1 (n = 13) | G2/3 (n = 45) | P value | |
---|---|---|---|
VEGF Median pg/mg protein (range, min–max) |
257.76 (0–1265.8) | 625.35 (10.14–3,000.0) | 0.019 |
EMMPRIN Median ng/mg protein (range, min–max) |
25.92 (8.48–44.25) | 35.90 (10.86–106.50) | 0.026 |
bFGF Median ng/mg protein (range, min–max) |
2.19 (0.72–13.32) | 0.82 (0.17–8.33) | 0.018 |
CD105-MVD Median vessels/mm2 (range, min–max) |
6 (0–44) | 28 (0–57) | 0.017 |
CD31-MVD Median vessels/mm2 (range, min–max) |
63 (25–241) | 76 (19–203) | 0.223 |
CD34-MVD Median vessels/mm2 (range, min–max) |
54 (6–146) | 76 (32–190) | 0.153 |
CD105-MVD, CD31-MVD, and CD34-MVD refer to MVD assessed with antibodies against CD105, CD31, and CD34, respectively
Bold values are statistically significant (P < 0.05)